Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Median Effective Dose of Esketamine Pretreatment to Prevent Sufentanil-induced Cough

NCT05809804 is registered in ClinicalTrials.gov with Yangzhou University as lead sponsor.

NCT NCT05809804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05809804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Median Effective Dose of Esketamine Pretreatment to Prevent Sufentanil-induced Cough
Lead sponsor
Yangzhou University
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2023
Completion date
July 1, 2023
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

esketamine, sufentanil